Guide for Authors

All journal information and instructions compiled in one document (PDF) in just one mouse-click Download Guide for Authors in PDF

Beginning in 2021, BBMT will formally change its name to Transplantation and Cellular Therapy. We are also excited to announce that we will be changing the print format of the journal to give our readers the most up to date, exciting research in hematopoietic stem cell transplantation.

Regular articles (i.e. Original Research articles) will now only print an extended, structured abstract. Editorials, Brief articles, Letters, Review articles, Clinical Reviews, ASTCT Publications and Guidelines, the Featured Article and corresponding Bottom Line articles will continue to print in full and do not require an extended, structured abstract. ALL articles will appear in full, in the online version of the journal on ScienceDirect.

Extended abstracts will publish for all "regular" articles, i.e. regular manuscripts and rapid publications. These extended abstracts will publish in print and online – the rest of the full manuscript will publish online-only. For more information on structured abstracts please click here.

Regular abstracts will be acceptable for review articles, clinical reviews, editorials, letters (if abstracts are necessary for the article type) – full manuscripts will publish in print and online.

Your Paper Your Way

We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
To find out more, please visit the Preparation section below.

Categories of manuscripts

Brief Articles. Reserved for cutting edge early studies that would highly impact the field. Manuscripts in this category are in the same format as a Regular Article, but are generally less than 20 total manuscript pages in length (double-spaced) and have three or less figures or tables.

Regular Manuscripts. Manuscripts submitted in this category are expected to be concise, well organized, and clearly written. Acceptance is based on originality and importance to the field of transplantation and cellular therapy. These manuscripts are reviewed by two or more experts in the field, and detailed comments from the reviewers are generally returned to the authors. Manuscripts requiring extensive revision will be at a disadvantage for publication. Manuscripts are submitted with the understanding that they are original contributions and do not contain data that have been published elsewhere, including symposia volumes, etc. Meeting abstracts do not constitute prior publication. A structured abstract is required.

Rapid Publications. Definitive papers of exceptional scientific importance within the discipline of transplantation and cellular therapy will be considered for expedited review and publication. Consideration as a Rapid Publication must be requested at the time of submission by the authors and requires approval by the Editorial Board. Papers that the Editors decide not to process as Rapid Publications will be handled as regular manuscripts unless the authors choose to have them returned without further review. Criteria for selection as Rapid Publications include originality, importance, and the potential value of accelerated publication to the readers of Transplantation and Cellular Therapy. Decisions on these manuscripts will be made within four weeks of receipt and in general will not be accompanied by detailed reviewers' comments. Although there is no page limit for manuscripts in this category, clear and concise presentation of data is required. Manuscripts requiring extensive revisions or editing will be at a disadvantage for publication in this category. Case reports, methods papers, or preliminary studies should not be submitted for consideration as Rapid Publications.A structured abstract is required.

Review Articles. Review articles on topics of broad interest are highly desired and may be solicited by the Editor-in-Chief. Individuals who wish to write a review article should correspond with the Editor in Chief regarding the appropriateness of the proposed topic. Such articles are expected to be thorough and detailed and should include appropriate references to the literature. The addition of tables and figures to summarize critical points is encouraged. These articles are reviewed by the Editors and other expert reviewers before a final decision regarding publication is made, and revisions may be required. Review articles should be limited to no more than 5,000 words (exclusive of references)and no more than 80 references.

Clinical Reviews. Short, highly focused articles that review topics related to therapy, diagnosis, or other clinical issues in hematology may be published as Clinical Reviews. Authors who wish to write a Clinical Review should correspond with the Editor in Chief regarding the proposed topic. Such manuscripts will be reviewed by expert reviewers and will be accepted for publication based on their educational value and clarity. Manuscript submission fees and page charges are not assessed on review articles.

Editorials. Concise, invited commentaries on articles published in Transplantation and Cellular Therapy or other topics in hematology are highly desired.

Letters. Letters to the Editor commenting on articles published in Transplantation and Cellular Therapy are welcomed. Letters should be as concise as possible (no more than three double-spaced pages), include no more than 10 references, and should have titles.

Case Reports are not published in Transplantation and Cellular Therapy, and will not be accepted in any format.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address

All necessary files have been uploaded:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)

Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

Ethics in publishing

Please see our information on Ethics in publishing.

Ethical considerations

Transplantation and Cellular Therapy considers research and publication misconduct to be a serious breach of ethics, and will take such actions as necessary to address such misconduct. Authors should refer to the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors for full information. Authors are also encouraged to visit Elsevier's Ethical Guidelines for Journal Publication.

Plagiarism and duplicate submission are serious acts of misconduct. Plagiarism is defined as unreferenced use of published or unauthorized use of unpublished ideas, and may occur at any stage of planning, researching, writing, or publication. Plagiarism takes many forms, from 'passing off' another's paper as the author's own paper, to copying or paraphrasing substantial parts of another's paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Duplicate submission/publication occurs when two or more papers, without full cross-reference, share the same hypothesis, data, discussion points, or conclusions.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. When coding terminology is used, we recommend to avoid offensive or exclusionary terms such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and (self-) explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.


All material in Transplantation and Cellular Therapy represents the opinions of the authors and does not reflect the opinions of the American Society for Transplantation and Cellular Therapy (ASTCT), Elsevier Inc., or the institutions with which the authors are affiliated. Authors submitting manuscripts do so with the understanding that, if accepted, copyright in the article, including the right to reproduce the article in all forms and media including electronic media, shall be assigned exclusively to the ASTCT and authors will be requested to sign a copyright release form.


Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.

Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.

Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.

NIH Public Access Policy compliance

To comply with the NIH Public Access Policy, Elsevier will deposit to PubMed Central (PMC) author manuscripts on behalf of authors reporting NIH funded research. The NIH policy requires that NIH-funded authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed author manuscripts, to appear on PMC no later than 12 months after final publication. Elsevier will send to PMC the final peer-reviewed manuscript, which was accepted for publication and sent to Elsevier's production department, and that reflects any author-agreed changes made in response to peer-review comments. Elsevier will authorize the author manuscript's public access posting 12 months after final publication. Following the deposit by Elsevier, authors will receive further communications from the NIH with respect to the submission.

Note: Authors must declare their NIH funding (or the other funding bodies listed below) when completing the copyright transfer form.

Other Funding Body Policies

Elsevier has also worked with the following funding bodies to ensure that our authors can comply with their policies:

- Arthritis Research Campaign (UK)

- British Heart Foundation (UK)

- Cancer Research (UK)

- Chief Scientist Office

- Department of Health (UK)

- Howard Hughes Medical Institute (US)

- Medical Research Council (UK)

- Wellcome Trust (UK)

For full details on how these policies are implemented, please see complete information at:

Open access options

Please visit our Open Access page for more information.

Manuscript submission and handling

Transplantation and Cellular Therapy utilizes a web-based manuscript submission and peer-review system. Authors should submit their manuscripts at Complete instructions are available at the Web site. If authors experience any difficulty during the submission process or require any assistance, they should visit If authors do not receive an e-mail confirmation of submission within 24 hours, it may be an indication that the manuscript has not been received by the editorial office. In this instance, authors should contact the editorial office (Robert Korngold, PhD, Hackensack University Medical Center, 40 Prospect Avenue – Rm 356 Jurist Research Building, Hackensack, NJ 07601; Tel: (551) 996-8664; Fax: (551) 996-8696; Email:


Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
As part of the Your Paper Your Way service, you may choose to submit your manuscript as a single file to be used in the refereeing process. This can be a PDF file or a Word document, in any format or lay-out that can be used by referees to evaluate your manuscript. It should contain high enough quality figures for refereeing. If you prefer to do so, you may still provide all or some of the source files at the initial submission. Please note that individual figure files larger than 10 MB must be uploaded separately.

There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the article number or pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct.

Formatting requirements
There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with Captions.
If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.
Divide the article into clearly defined sections.

Figures and tables embedded in text
Please ensure the figures and the tables included in the single file are placed next to the relevant text in the manuscript, rather than at the bottom or the top of the file. The corresponding caption should be placed directly below the figure or table.


Use of word processing software
Regardless of the file format of the original submission, at revision you must provide us with an editable file of the entire article. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

Organization of the manuscript

Organize submitted manuscripts as follows: Cover Letter, Title Page (including title; authors' full names, academic degrees, and affiliations; corresponding author's address, phone number, fax number, and e-mail address; and a short title), Financial Disclosure Statement, Abstract (please review whether the abstract required for your article type should be structured), Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figure Legends, and Figures. Manuscripts should be double-spaced and formatted for standard paper with 1-inch margins.

Cover Letter. Please identify the name, address, phone number, fax number, and e-mail address of the corresponding author. The cover letter should also specify the category of manuscript (such as Rapid Communication). Papers that the Editors decide not to process as Rapid Communications will be handled as regular manuscripts unless the authors request in the cover letter that the manuscript be returned without further review. The cover letter also should indicate where appropriate that the authors are willing to pay the extra costs involved in publishing any color photographs.


Highlights are mandatory for this journal as they help increase the discoverability of your article via search engines. They consist of a short collection of bullet points that capture the novel results of your research as well as new methods that were used during the study (if any). Please have a look at the examples here: example Highlights.

Highlights should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point).

Structured abstract
A structured abstract consists of up to 500 words (250-word minimum) with the following required headings:

1. Background: an explanation of the basis for the study.
2. Objective(s): the purpose of the study (hypothesis being tested).
3. Study Design: the setting for the study, subjects (number and type), treatment or intervention, and type(s) of statistical analysis used.
4. Results: the outcome(s) of the study and, if appropriate, their statistical significance.
5. Conclusion(s): overall significance of the results.

The abstract should provide sufficient detail for the editors, reviewers, and readers to clearly understand the main message of your paper. Abstracts are freely available on search engines such as Scopus, PubMed, etc., and are a key component in assessing the quality of an article. We welcome graphical abstracts and encourage inclusion of up to 2 tables, figures or images. Color charges for any manuscript printed as an extended abstract only (i.e. Original Research Articles) will be waived for authors.

Graphical abstract
Although a graphical abstract is optional, its use is encouraged as it draws more attention to the online article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You can view Example Graphical Abstracts on our information site.
Authors can make use of Elsevier's Illustration Services to ensure the best presentation of their images and in accordance with all technical requirements.


Abbreviations should be defined at their first use and applied consistently throughout the article. Do not use nonstandard abbreviations or abbreviate terms appearing fewer than three times. Give the chemical name of a compound after the first use of the trivial name. The trivial name may follow throughout the article.

Financial disclosure statement

Authors must disclose any primary financial relationship with a company that has a direct financial interest in the subject matter or products discussed in the submitted manuscript, or with a company that produces a competing product. These relationships (such as honoraria, ownership of stock, patents, or consulting fees) and any direct support of research by a commercial company will be included in the Acknowledgements section of the published article.

Footnotes should be used sparingly. Number them consecutively throughout the article. Many word processors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article.

Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Indicate per figure if it is a single, 1.5 or 2-column fitting image.
• For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage.
• Please note that individual figure files larger than 10 MB must be provided in separate source files.

A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
Regardless of the application used, when your electronic artwork is finalized, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'.
TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low.
• Supply files that are too low in resolution.
• Submit graphics that are disproportionately large for the content.

Part of the cost of publishing color photographs will be borne by the authors and payment must be made to the publisher prior to publication. The cost to publish color figures in print is $500 for the first color figure and $100 for each additional color figure.

Figures and figure legends

Figures must be cited in the text in numerical order using Arabic numerals. Figures should be generated in .tif format; see instructions on Web site. Figure legends should be double-spaced on a separate page and should include a brief title and a concise explanation of each figure.

Figure captions
Ensure that each illustration has a caption. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.


Each table should be printed or typed on a separate page, appropriately numbered and cited in numerical order in the text. Legends giving sufficient explanation to make the data intelligible without reference to the text must be typed on the same page.


Include double-spaced references in numerical order at the end of the article according to the order of citation in the text. The names of all authors should be given unless there are more than 6, in which case the names of the first 3 authors should be given, followed by "et al." Abbreviate the names of journals according to the abbreviations used in the latest edition of Index Medicus, Superintendent of Documents, US Government Printing Office, Washington, DC 20402. References to abstracts and letters must be appropriately identified. References to personal communications, unpublished observations, and manuscripts submitted and "in preparation" must appear parenthetically in the text.

If you do wish to format the references yourself they should be arranged according to the following examples:

9. Singer JW, Charbord P, Keating A, et al. Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics. Biol Blood Marrow Transplant. 1995;7:464-469.

10. Cone RD, Williams DA, Davies TF. Establishment of differentiated cell lines using oncogene-containing retroviral vectors. In: Glunzman Y, Hughes SH, eds. Viral Vectors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1993:34-39.
[dataset] 5. Oguro, M, Imahiro, S, Saito, S, Nakashizuka, T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015.
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct.

Reference links
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is highly encouraged.

A DOI is guaranteed never to change, so you can use it as a permanent link to any electronic article. An example of a citation using DOI for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M. (2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal of Geophysical Research, Please note the format of such citations should be in the same style as all other references in the paper.

Data references
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.

Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the name of the preprint server, as part of the reference. The preprint DOI should also be provided.

Reference management software
Most Elsevier journals have their reference template available in many of the most popular reference management software products. These include all products that support Citation Style Language styles, such as Mendeley. Using citation plug-ins from these products, authors only need to select the appropriate journal template when preparing their article, after which citations and bibliographies will be automatically formatted in the journal's style. If no template is yet available for this journal, please follow the format of the sample references and citations as shown in this Guide. If you use reference management software, please ensure that you remove all field codes before submitting the electronic manuscript. More information on how to remove field codes from different reference management software.

Supplementary material for online publication

In cases where essential information associated with an article is too extensive for print publication (e.g., data sets, additional figures, video files), this content can be included as online-only supplemental information. Supplementary material file(s) should be provided at the time of manuscript submission, and should be called out in the text (egg, Table S2, Fig S1, Item S4). Titles and/or legends for each supplementary figure or item should be included as the final page of the manuscript document. Unless otherwise requested, supplementary material will generally be corrected for style, grammar, and format.

Research data

This journal encourages and enables you to share data that supports your research publication where appropriate, and enables you to interlink the data with your published articles. Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.

Below are a number of ways in which you can associate data with your article or make a statement about the availability of your data when submitting your manuscript. If you are sharing data in one of these ways, you are encouraged to cite the data in your manuscript and reference list. Please refer to the "References" section for more information about data citation. For more information on depositing, sharing and using research data and other relevant research materials, visit the research data page.

Data linking
If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that gives them a better understanding of the research described.

There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. For more information, visit the database linking page.

For supported data repositories a repository banner will automatically appear next to your published article on ScienceDirect.

In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN).

Data statement
To foster transparency, we encourage you to state the availability of your data in your submission. This may be a requirement of your funding body or institution. If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why during the submission process, for example by stating that the research data is confidential. The statement will appear with your published article on ScienceDirect. For more information, visit the Data Statement page.


Authors of accepted manuscripts will receive galley proofs as pdf files via e-mail directly from the publisher and are responsible for proofreading. Except for correcting typesetting errors, authors may be charged for extensive alterations. Corrections should be returned within 48 hours to avoid delay in publication.


The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Author Services. Corresponding authors who have published their article gold open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.


Reprints must be ordered and paid for in advance. An order form with the cost of reprints and instructions for payment will be sent directly from the publisher with page proofs. Reprint orders, payments, and inquiries should be directed to Elsevier.


Announcements of meetings that are of interest to the readers of Transplantation and Cellular Therapy should be sent to the Editor at least three months before the first day of the month of issue. Fees for announcements vary depending on their size and number of insertions; please call the Editorial Office for details.


Direct inquiries about advertising and classified ads to Neethu Joseph, Elsevier, 360 Park Avenue South, New York, NY 10010-1710,, telephone 212-462-1917.

Publisher contact information: